Nirmatrelvir Covid-19 drug action, molecular model
Numéro d’image : 13527320
| Molecular model of the Covid-19 drug Nirmatrelvir (red) binding to and inhibiting the the 3C-like protease (blue) of the SARS-CoV-2 virus. Nirmatrelvir is an antiviral medication developed to treat Covid-19, which is caused by the SARS-CoV-2 virus. 3C-like protease, also known as main protease, processes two long polyproteins that the virus needs to replicate new viruses. | |
| Licence : | Libre de droits |
| Crédit: | Science Photo Library / Gaertner, Juan |
| Model Release : | Non requis |
| Property Release : | Non requis |
| Restrictions : | - |
Prix pour cette image À partir de 29 €
Pour une utilisation numérique (72 dpi)
À partir de 29 €
Pour un usage d'impression (300 dpi)
À partir de 325 €
Mots clés
- 2019 ncovid,
- 2019-ncovid,
- 3 dimensions,
- 3D,
- action,
- antiviral,
- attacher,
- aucun,
- biochimie,
- biochimique,
- corona virus,
- coronavirus,
- covid 19,
- covid-19,
- covid19,
- drogue,
- enzyme,
- fond bleu,
- hydrolase,
- illustration,
- inhibiteur,
- lier,
- médecine,
- médication,
- modèle,
- moléculaire,
- molécule,
- oeuvre,
- personne,
- pharmacologie,
- pharmacologique,
- protéase,
- protéine,
- SARS Cov 2,
- traitement